Optimized expression of HPV 52 L1 in yeast
Details for Australian Patent Application No. 2005230907 (hide)
International Classifications
Event Publications
19 October 2006 PCT application entered the National Phase
PCT publication WO2005/097821 Priority application(s): WO2005/097821
28 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
19 May 2011 Application Accepted
Published as AU-B-2005230907
15 September 2011 Standard Patent Sealed
11 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005230915-Compounds and methods for treating dyslipidemia
2005230902-Non-imidazole heterocyclic compounds as histamine H3-receptor ligands
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser